AMSTAR 2仅部分适用于对非干预研究的系统审查:一个元研究研究
Livia Puljak1, Malgorzata M Bala2, Tim Mathes3
1Center for Evidence-Based Medicine and Healthcare, Catholic University of Croatia, Zagreb, Croatia.
Journal of clinical epidemiology
|September 2, 2023
概括
评估系统审查2的评估工具 (AMSTAR 2) 仅部分适用于非干预系统审查 (SRs). 需要进一步调整以充分评估这些重要的研究综合的质量.
科学领域:
- 超级研究的研究.
- 证据综合方法论的方法论.
- 卫生科学研究 卫生科学研究
背景情况:
- 评估系统审查2的评估工具 (AMSTAR 2) 是广泛用于评估医疗干预措施的系统审查 (SRs) 的工具.
- 它对专注于非干预主题的SR的适用性,例如诊断测试准确性,病因学,流行率,发病率和预后,尚未被彻底评估.
研究的目的:
- 评估AMSTAR 2工具对各种类型的非干预系统审查的适用性.
- 确定哪些AMSTAR 2项目在不同SR类型中普遍适用,哪些需要调整.
主要方法:
- 进行了一项超级研究,使用四个非干预类别的80个系统审查:诊断测试准确性,病因/风险,流行/发病率和预后审查.
- 三位独立审查员将AMSTAR 2检查清单应用于每个系统性审查,并评估了每个项目的适用性.
主要成果:
- 在16个AMSTAR 2项目中,有7项被一致认为适用于所有四种非干预SR类型和任何SR类型.
- 这些普遍适用的项目 (2,5,6,7,10,14,16) 涵盖了通用的系统审查方法.
- 然而,AMSTAR 2对非干预SRs的整体适用性被发现是部分的.
结论:
- 为了充分适用于评估非干预系统审查,AMSTAR 2 工具需要进行调整或扩展.
- 这项研究强调了为非干预SRs制定量身定制的方法预期的必要性.
- 结果可以为完善现有工具和开发新的工具提供信息,用于在不同研究领域进行全面的SR质量评估.
相关概念视频
01:23Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
147
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
147
01:20Comparing the Survival Analysis of Two or More Groups
222
Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and...
222
01:20Study Designs in Epidemiology
264
Epidemiological study designs are fundamental tools for investigating the distribution, determinants, and control of health conditions in populations. They help researchers understand the relationships between exposures and outcomes, and they broadly fall into two categories: "observational" and "experimental" studies.
Observational studies are those where the researcher does not intervene but rather observes natural variations. They include cross-sectional, cohort, and...
Observational studies are those where the researcher does not intervene but rather observes natural variations. They include cross-sectional, cohort, and...
264
01:12Statistical Methods to Analyze Parametric Data: ANOVA
425
Analysis of Variance, or ANOVA, is a powerful statistical technique used to analyze parametric data, primarily in research and experimental studies. It's designed to compare the means of two or more groups, assisting researchers in identifying any significant differences between these group means. There are two main types of ANOVA based on the complexity of the analysis: one-way and two-way.
One-way ANOVA is applied when a single independent variable or factor is scrutinized. It compares...
One-way ANOVA is applied when a single independent variable or factor is scrutinized. It compares...
425
01:14SBAR II: Application of SBAR
4.5K
SBAR is an effective communication tool used by healthcare professionals to communicate patient information accurately. SBAR stands for Situation, Background, Assessment, and Recommendation. For a better understanding, an example is given below.
SBAR Report from a Nurse to a Health Care Provider
S: "Hello, Dr. Smith. This is Jane, RN, from the Med Surg unit. I am calling to tell you about Ms. White in Room 210, who is experiencing increased pain and redness at her incision site. Her recent...
SBAR Report from a Nurse to a Health Care Provider
S: "Hello, Dr. Smith. This is Jane, RN, from the Med Surg unit. I am calling to tell you about Ms. White in Room 210, who is experiencing increased pain and redness at her incision site. Her recent...
4.5K
01:11Clinical Trials: Overview
3.0K
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
3.0K